Secure platforms support for the N3C data enclave (covid-19)
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95021D00029
- Awardee
-
Palantir Technologies Inc. UEI FSY4LVSBGWB7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 8 $35,289,001 obligated
Award facts
- Opportunity
-
- 75N95021R00068 Solicitation number
- Combined order value
- $35,289,001 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 59% used
- $59,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 511210 Software Publishers
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a single award indefinite delivery contract to Palantir Technologies Inc. with a potential value of $59.5 million. The contract provides secure platforms support for the N3C Data Enclave to support COVID-19 efforts.
Under the contract, eight firm fixed price delivery orders have been awarded to Palantir Technologies Inc. totaling over $40 million to date. The delivery orders provide data management and analytics platform support through Palantir's secure data integration and analytics software. Places of performance are in Denver, Colorado for periods generally between four to eight months. The National Center for Advancing Translational Sciences aims to enable COVID-19 research through the provision of these secure data and analytics capabilities to the N3C Data Enclave.
No set asides were used for the contract or associated delivery orders. The National Center for Advancing Translational Sciences and National Institute on Drug Abuse, both parts of the National Institutes of Health, require these services to support their COVID-19 translational research efforts through effective data integration and analysis. Palantir Technologies Inc. is providing its proprietary data analytics platform to meet this need.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95021D00029?
75N95021D00029 was awarded to Palantir Technologies Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 28, 2021.
How much is contract 75N95021D00029 worth?
Orders under 75N95021D00029 have obligated $35,289,001. 75N95021D00029's own ceiling is $59,500,000.
How many orders have been placed under contract 75N95021D00029?
8 orders have been placed under 75N95021D00029, the latest on August 2, 2023.
Which agency awarded contract 75N95021D00029?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021D00029, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Who can order from contract 75N95021D00029?
75N95021D00029 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95021D00029 competed?
The extent of competition for 75N95021D00029 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV